The use of angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs), and statins in CKD patients may mitigate the effects of air pollution on kidney function decline through antioxidant stress mechanisms [41–43]. This evidence concerns the gene ACE and chronic kidney disease.